Home
Dashboard
Curated content
Startups & Scaleups
New startups
Jobs
Corporates
Investors
Funding rounds
Exits
Accelerators
Workspaces
Universities
More organizations
Matching tool
Investment heatmap
Themes
News
Companies
Amblyotech
Save
Amblyotech
closed
Developer of novel electronic media therapies designed for the treatment of amblyopia and other ocular diseases.
Launch date
2013
Market cap
-
Enterprise valuation
€1—2m
(Dealroom.co estimates Jan 2018.)
Atlanta Georgia (HQ)
http://amblyotech.com
https://twitter.com/novartis
https://www.facebook.com/610959839003874
B2C
saas
commission
health
health platform
hard tech
surgery
eye diseases
Overview
Similar companies
Investments (8)
Analytics
Notes
Job openings
Innovations (0)
Amblyotech funding
Amblyotech investors
Edit
Date
Investors
Amount
Round
-
Jumpstart Foundry
N/A
-
Jan 2017
N/A
$200k
Seed
Jan 2018
N/A
$400k
Seed
Apr 2020
*
Novartis
N/A
Acquisition
Total Funding
€545k
Recent News about Amblyotech
Edit
Tech stack
Group
Tech stack
Learn more about the technologies and tools that this company uses.
Login for access
Investments by Amblyotech
Edit
Intellia Therapeutics
exited
XOMA
exited
Aduro BioTech
exited
Ayala Pharmaceuticals
exited
Poseida Therapeutics
exited
Immunitas Therapeutics
Dunad Therapeutics
Medtech Africa